American Journal of Engineering & Natural Sciences (AJENS) ISSN 2074-112X

Original Research Contributions in Genetic Biongineering And Natural Genome Editing

fallback-image

Adar Biotech

Lab Reagents

Adar Biotech Laboratories manufactures the adar biotech reagents distributed by Genprice. The Adar Biotech reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Adar Biotech. Other Adar products are available in stock. Specificity: Adar Category: Biotech

Serum / Plasma information

ADAR Conjugated Antibody

C37084 100ul
EUR 476.4

ADAR Conjugated Antibody

C49758 100ul
EUR 476.4

Anti-ADAR antibody

STJ110179 100 µl
EUR 332.4
Description: This gene encodes the enzyme responsible for RNA editing by site-specific deamination of adenosines. This enzyme destabilizes double-stranded RNA through conversion of adenosine to inosine. Mutations in this gene have been associated with dyschromatosis symmetrica hereditaria. Alternative splicing results in multiple transcript variants.

Perforated Shelf For RS Biotech Galaxy 14

INC6166 EACH
EUR 147.06

Human ADAR shRNA Plasmid

20-abx950067
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

ADAR Antibody, HRP conjugated

1-CSB-PA001324LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against ADAR. Recognizes ADAR from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

ADAR Antibody, FITC conjugated

1-CSB-PA001324LC01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against ADAR. Recognizes ADAR from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

ADAR Antibody, Biotin conjugated

1-CSB-PA001324LD01HU
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against ADAR. Recognizes ADAR from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Mouse ADAR shRNA Plasmid

20-abx974757
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Rat ADAR shRNA Plasmid

20-abx986611
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

ADAR ELISA KIT|Human

EF007278 96 Tests
EUR 826.8

Human ADAR ELISA KIT

ELI-26127h 96 Tests
EUR 988.8

Mouse Adar ELISA KIT

ELI-31602m 96 Tests
EUR 1038

pCMV-SPORT6-ADAR Plasmid

PVTB00888 2 ug
EUR 427.2

Multi shelf rack For RS Biotech Galaxy 48R

INC6474 EACH
EUR 393.3

Additional perforated shelf For RS Biotech Galaxy 48R

INC6476 EACH
EUR 111.72

ADAR ELISA Kit (Human) (OKCA01209)

OKCA01209 96 Wells
EUR 1015.2
Description: Description of target: Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2) and serotonin (HTR2C) and GABA receptor (GABRA3). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alters their functional activities. Exhibits low-level editing at the GRIA2 Q/R site, but edits efficiently at the R/G site and HOTSPOT1. Its viral RNA substrates include: hepatitis C virus (HCV), vesicular stomatitis virus (VSV), measles virus (MV), hepatitis delta virus (HDV), and human immunodeficiency virus type 1 (HIV-1). Exhibits either a proviral (HDV, MV, VSV and HIV-1) or an antiviral effect (HCV) and this can be editing-dependent (HDV and HCV), editing-independent (VSV and MV) or both (HIV-1). Impairs HCV replication via RNA editing at multiple sites. Enhances the replication of MV, VSV and HIV-1 through an editing-independent mechanism via suppression of EIF2AK2/PKR activation and function. Stimulates both the release and infectivity of HIV-1 viral particles by an editing-dependent mechanism where it associates with viral RNAs and edits adenosines in the 5'UTR and the Rev and Tat coding sequence. Can enhance viral replication of HDV via A-to-I editing at a site designated as amber/W, thereby changing an UAG amber stop codon to an UIG tryptophan (W) codon that permits synthesis of the large delta antigen (L-HDAg) which has a key role in the assembly of viral particles. However, high levels of ADAR1 inhibit HDV replication.1;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 5.86 pg/mL

Recent Posts

February 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728  

Tags

Categories